Innocare

Developer of small molecule based therapeutics for the treatment of cancer and autoimmune disorders

placeBeijing, Beijing, China calendar_todayFounded 2015 groups1,072 employees language innocarepharma.com

Social engagement

Social engagement: 5.6K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Vivo Capital, Loayal Valley Capital.

Investor typeCountShare
Venture capital330%
Private equity330%
Bank & private debt220%
Other / undisclosed220%

Recent activity

2 Jul 2026
Recognition
Coming soon